Navigation Links
Vion Pharmaceuticals Announces FDA Lift of Clinical Hold on Phase III Study of Cloretazine(R) (VNP40101M) and Cytarabine in Relapsed AML
Date:1/8/2008

erly patients with de novo poor-risk AML. Preliminary data from this study were presented at the 2007 Annual Meeting of the American Society of Hematology (ASH(R)) in December 2007.

Conference Call Details

Vion will hold a conference call on Tuesday, January 8, 2008, at 10:30 a.m. Eastern Time. To participate in the conference call, please dial (866) 825-3209 in the U.S. (617) 213-8061 for international callers) at least 15 minutes before the start of the call. When prompted for a passcode, please enter 77697895. An audio webcast of the call will be accessible at http://www.vionpharm.com. Those who wish to listen to the conference call on the Web should visit the Investor Relations section of the Company's website at least 15 minutes prior to the event broadcast, and follow the instructions provided to assure that the necessary audio applications are downloaded and installed. These programs can be obtained at no charge to the user. A replay of the call will be available two hours after the completion of the call at (888) 286-8010 in the U.S. ((617) 801-6888 for international callers), pass code 45545274.

Vion Pharmaceuticals, Inc. is committed to extending the lives and improving the quality of life of cancer patients worldwide by developing and commercializing innovative cancer therapeutics. Vion has two agents in clinical trials. Cloretazine(R) (VNP40101M), a unique alkylating agent, is being evaluated in a Phase II pivotal trial as a single agent in elderly patients with previously untreated de novo poor-risk acute myelogenous leukemia. Clinical trials of Cloretazine(R) (VNP40101M) as a single agent in small cell lung cancer, with temozolomide in brain tumors, and with stem cell transplantation in advanced hematologic malignancies, are also being conducted. Triapine(R), a potent inhibitor of a key step in DNA synthesis, is being evaluated in clinical trials sponsored by the National Cancer
'/>"/>

SOURCE Vion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...Nov. 9 /PRNewswire-Asia/ -- Chindex International,...pendent American provider of Western,healthcare pr...ina, today,announced results for the second quarte...mber 30, 2009. , , Financial Highlights:, -... $38.1 million, flat on, a year over year ba...
(Date:11/9/2009)...ov. 9 Caliper Life Scien...tools and services for drug discovery and life sci...iscovery Alliances and Services (CDAS) unit has be...on under its contract with the Environmental Prote... program. This new task order increases the cumul...
(Date:11/6/2009)...6 Oxygen Biotherapeutics...that a previously approved reverse split of its co...g on Monday, Nov. 9, 2009 on a 1-for-15 split-adju...ll trade under the new symbol OXBT. The stock also...he split becomes effective. ,, "This reverse sp...
Breaking Medicine Technology:Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 2Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 3Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 4Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 5Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 6Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 7Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 8Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 9Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 10Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 11Caliper Awarded New Task Order for EPA ToxCast Program 2Caliper Awarded New Task Order for EPA ToxCast Program 3Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 2Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 3The Female Health Company Schedules Third Quarter Conference Call for August 7 2009 53333 1The Female Health Company Schedules Third Quarter Conference Call for August 7 2009 53333 2The Female Health Company Schedules Third Quarter Conference Call for August 7 2009 53333 3NxStage to Present at the Canaccord Adams Global Growth Conference 53331 1NxStage to Present at the Canaccord Adams Global Growth Conference 53331 2China Biotics Inc Applies for Four Patents on Probiotic Formulations 13304 1China Biotics Inc Applies for Four Patents on Probiotic Formulations 13304 2China Biotics Inc Applies for Four Patents on Probiotic Formulations 13304 3
...ollaborates with Dikembe Mutombo Foundation to imp...of the Congo, NEW YORK, Sept. 25 The Clinton Glo...d Company) (NYSE: BDX ), a,leading global medical...embe Mutombo Foundation (DMF) to enhance immune sy...e Biamba Marie Mutombo Hospital (BMMH) and,Researc...
..., Mo., Sept. 25 The National Autism,Association (...ling $30,000,for its Progress Research Fund from f...xpresses its sincere gratitude to Bruce and Kelly ...ontribution of $20,000 made by two,other parents f...ndrew,Wakefield. NAA research chair and founding b...
Other Medicine Technology:Clinton Global Initiative Announces BD's Commitment to Biamba Marie Mutombo Hospital 2Clinton Global Initiative Announces BD's Commitment to Biamba Marie Mutombo Hospital 3Parents Make Donations to National Autism Association for Cutting-Edge Research 2
(Date:11/9/2009)... lives of almost 4 million women, newborns, and ch...year if well-established, affordable health care i...ding to a joint report by the national science aca...ations are underutilizing existing scientific know...on scientists, health care providers, policymakers...
(Date:11/9/2009)...flu could be severe in this group of women, study ...ws) -- Pregnant women who are depressed may suffer... study suggests. , Ohio State University resear...samples from 22 pregnant women before they receive...toms of depression had a stronger inflammatory res...
(Date:11/9/2009)... Dr. Mark Sweeney, a cosmetic dentist in Aust...ting participants to describe why they are The Mos...ner earns a cosmetic smile makeover worth up to $1...n Dental Spa’s website as well as YouTube an...ember 9, 2009 -- A prominent Austin cosmetic dent...
(Date:11/9/2009)... Partnership to bring next generation of sport...s. , Colorado Springs, CO...- The United States Olympic Committee (USOC) and ...announced a strategic partnership in which D.I.S.C...r through the 2012 Olympic Games. With this agreem...
(Date:11/9/2009)... Partnership to Combine Self-service Kiosks an... Denver, CO (PRWEB) November 9...and AHA endorsed Vecna Technologies announced toda...l when interacting with providers by understanding...HSCorp’s HFMA peer reviewed product, ClearQu...
Breaking Medicine News(10 mins):Health News:Using science to save lives of mothers and children in Africa 2Health News:Using science to save lives of mothers and children in Africa 3Health News:Using science to save lives of mothers and children in Africa 4Health News:Depressed and Pregnant? Flu Shot May Be Needed 2Health News:Austin Cosmetic Dentist Offers $15,000 Worth of Dental Work in Most Interesting Patient in the World Video Contest 2Health News:Austin Cosmetic Dentist Offers $15,000 Worth of Dental Work in Most Interesting Patient in the World Video Contest 3Health News:United States Olympic Committee Announces D.I.S.C. Sports and Spine Center as an Official Medical Services Provider 2Health News:United States Olympic Committee Announces D.I.S.C. Sports and Spine Center as an Official Medical Services Provider 3Health News:FHS Corp. Announces Partnership with Vecna Technologies 2
... October 8 - Report Suggests Millions of Sports ...y(C) released by Litozin joint health reveals that... be damaging their joints. Over,two thirds (68%) o...e nations top,sports performers with David Beckham...
...is improves in summer, fall, study finds , SUNDAY,...state cancer in the summer and fall have a better ...ing and winter, a new study of Norwegian men sugge...ning factor, it does suggest that this possibility...
...l affective disorder sets in in the fall, experts ...-- If your mood, energy level, and motivation decl..., you may have seasonal affective disorder (SAD), ...ically overcast skies," says Dr. Angelos Halaris, ...
...Marketing Concepts, Inc. et al. Fights FTC for Fir...s, BOSTON, Mass., Oct. 5 The Federal Trade Commi...selling author and activist,Kevin Trudeau,s critic...st book, Weight Loss Cures "They" Don,t Want You t...
...Y, Calif., Oct. 5 Angel Flight West (AFW),awarded... John Birely at,AFW,s 24th Anniversary Awards on S... Flight West missions over the past year. As an AF...AFW volunteer,pilots, donates the cost of all the ...
...FALO, N.Y. -- For the more than 50 million America...- ringing in the ears that can range from annoying...be their best hope for finding relief. , Research...ers if they are experiencing tinnitus. , These sc...
Other Medicine News:Health News:More Damage Than Good? Shock Survey Reveals Sport can Actually be bad for Your Joints 2Health News:More Damage Than Good? Shock Survey Reveals Sport can Actually be bad for Your Joints 3Health News:Prostate Cancer Survival Varies by Season 2Health News:As Sunlight Fades, Look Out for SAD 2Health News:FTC Attacks Infomercial Marketer to Silence Best-Selling Author's Weight-Loss Tips 2Health News:Angel Flight West Recognizes Northern California Pilots at AFW 24th Anniversary Awards 2Health News:Scientists search for brain center responsible for tinnitus 2
...er unmatched performance through patient-focused c...e anesthesia solution developed, putting patient-f...ips., ,The Aisys Carestation is built on our indu...ivery and patient monitoring technology. We have i...
...e.g. Viagra, Injections and ,Penile implants) ar...ng increasing ,popularity by patients and their...ated benefits. ,In fact, Vacuum Therapy should b...nd to promote penile health. Evidence from leading...
...lypropylene mesh which offers an excellent bicompa...eaction. The softer, microfilament construction mi...ms to,anatomical structures. Due to its excellen...ments of the patient resulting from body motion. T...
Mega Power Electrosurgical Generator
Medicine Products: